Stocksigma LogoStocksigma Logo

Valiant Organics Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

■ Revenue: 30,422 (+93.4% YoY | +31.4% QoQ) ■ EBITDA: 3,902 (+84.1% YoY | -6.3% QoQ) ■ EBITDA Margin (%): 12.8 (-65 bps YoY | -515 bps QoQ) ■ PAT: 1,730

Valiant Organics Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

Valiant Organics Ltd · Outcome · 06 Nov 2026, 1:05 am

Valiant Organics Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 30,422 (+93.4% YoY | +31.4% QoQ) ■ EBITDA: 3,902 (+84.1% YoY | -6.3% QoQ) ■ EBITDA Margin (%): 12.8 (-65 bps YoY | -515 bps QoQ) ■ PAT: 1,730 (+205.2% YoY | -40.5% QoQ) ■ EPS (INR): 6.18 (+205.9% YoY | -40.8% QoQ) Valiant Organics Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) Segmental Performance Speciality Chemical Division ■ Revenue: 21,838 (+75.7% YoY | +24.3% QoQ) ■ EBIT: 2,057 (+49.4% YoY | -17.9% QoQ) ■ EBIT Margin (%): 9.4 (-166 bps YoY | -484 bps QoQ) Pharma Division ■ Revenue: 8,583 (+160.2% YoY | +53.8% QoQ) ■ EBIT: 940 (Loss to Profit YoY | -44.3% QoQ) ■ EBIT Margin (%): 10.9 (Loss to Profit YoY | -1926 bps QoQ)

Original exchange filing (PDF)

More announcements from Valiant Organics Ltd

All Valiant Organics Ltd announcements